Sensei Biotherapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
SNSE on Nasdaq
Industry
Pharmaceutical Preparations
Location
1405 Research Blvd, Suite 125, Rockville, MD

There are no Buy or Sell transactions made by insiders since 4/22/2024

Sensei Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cambrian BioPharma Inc 10%+ Owner $3.11M Jun 11, 2024
James Peyer Director, 10%+ Owner $3.11M Jun 11, 2024
Thomas G. Ricks Director $292K Jun 11, 2024
Robert Hamilton Pierce Chief R&D Officer $80.3K Feb 15, 2022
Erin Colgan Chief Financial Officer $53.3K Feb 15, 2024
John Celebi PRESIDENT AND CEO, Director $50.4K Feb 19, 2025
Patrick Stephen Gallagher Chief Business Officer $29K Feb 15, 2023
Edward van der Horst Chief Scientific Officer $28.5K Feb 19, 2025
Bob Holmen Director $21.8K Jun 11, 2024
William R. Ringo Director $19.9K Jun 11, 2024
Kristian Humer Director $7.59K Jun 11, 2024
Samuel Broder Director $7.59K Jul 10, 2023
Jessie English Director $7.59K Jun 11, 2024
Deneen Vojta Director $7.59K Jun 11, 2024
David Gaiero Principal Financial Officer May 10, 2024
Apeiron Investment Group Ltd. 10%+ Owner Jun 1, 2023
Josiah Craver Principal Financial Officer Feb 14, 2025
Stephanie Krebs Chief Business Officer Feb 14, 2025

Recent Insider Transactions by Companies or Individuals for Sensei Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.